The Clorox Company (NYSE:CLX) Shares Acquired by Bleakley Financial Group LLC

Bleakley Financial Group LLC boosted its position in The Clorox Company (NYSE:CLX) by 3.0% in the 3rd quarter, according to its most recent filing with the Securities and Exchange Commission. The fund owned 4,392 shares of the company’s stock after purchasing an additional 126 shares during the quarter. Bleakley Financial Group LLC’s holdings in Clorox were worth $716,000 as of its most recent filing with the Securities and Exchange Commission.

A number of other institutional investors and hedge funds also recently added to or reduced their stakes in CLX. GoalVest Advisory LLC purchased a new position in shares of Clorox during the first quarter valued at approximately $31,000. First Foundation Advisors acquired a new position in Clorox in the 1st quarter valued at $31,000. Innealta Capital LLC purchased a new position in shares of Clorox during the 2nd quarter worth $30,000. Trifecta Capital Advisors LLC boosted its holdings in shares of Clorox by 139.8% during the second quarter. Trifecta Capital Advisors LLC now owns 223 shares of the company’s stock worth $30,000 after purchasing an additional 130 shares during the last quarter. Finally, Quarry LP grew its position in shares of Clorox by 99.1% in the second quarter. Quarry LP now owns 229 shares of the company’s stock valued at $31,000 after purchasing an additional 114 shares during the period. 78.53% of the stock is currently owned by hedge funds and other institutional investors.

Wall Street Analysts Forecast Growth

Several equities analysts recently weighed in on CLX shares. Wells Fargo & Company reduced their target price on Clorox from $135.00 to $130.00 and set an “underweight” rating on the stock in a research report on Wednesday, July 10th. JPMorgan Chase & Co. raised their target price on shares of Clorox from $148.00 to $174.00 and gave the stock a “neutral” rating in a research report on Friday, October 11th. DA Davidson reaffirmed a “neutral” rating and set a $153.00 price target on shares of Clorox in a research report on Friday, September 6th. Citigroup lifted their price target on shares of Clorox from $165.00 to $170.00 and gave the company a “neutral” rating in a report on Friday, September 6th. Finally, Barclays upped their price objective on Clorox from $130.00 to $137.00 and gave the stock an “underweight” rating in a report on Friday, October 11th. Six analysts have rated the stock with a sell rating, nine have issued a hold rating and one has assigned a buy rating to the company’s stock. According to data from MarketBeat.com, the stock presently has a consensus rating of “Hold” and a consensus target price of $150.14.

Clorox Stock Performance

Clorox stock opened at $160.35 on Tuesday. The company has a debt-to-equity ratio of 5.04, a quick ratio of 0.63 and a current ratio of 1.03. The Clorox Company has a one year low of $114.68 and a one year high of $169.09. The stock’s 50 day moving average price is $159.65 and its 200 day moving average price is $145.24. The firm has a market capitalization of $19.91 billion, a PE ratio of 83.08, a price-to-earnings-growth ratio of 3.19 and a beta of 0.41.

Clorox (NYSE:CLX) last announced its earnings results on Thursday, August 1st. The company reported $1.82 earnings per share for the quarter, beating the consensus estimate of $1.54 by $0.28. Clorox had a net margin of 3.95% and a return on equity of 281.12%. The business had revenue of $1.90 billion during the quarter, compared to the consensus estimate of $1.97 billion. As a group, sell-side analysts expect that The Clorox Company will post 6.64 EPS for the current fiscal year.

Clorox Announces Dividend

The firm also recently announced a quarterly dividend, which will be paid on Thursday, November 7th. Stockholders of record on Wednesday, October 23rd will be given a dividend of $1.22 per share. This represents a $4.88 dividend on an annualized basis and a dividend yield of 3.04%. The ex-dividend date of this dividend is Wednesday, October 23rd. Clorox’s payout ratio is 252.85%.

Insider Buying and Selling

In other Clorox news, EVP Angela C. Hilt sold 1,733 shares of Clorox stock in a transaction that occurred on Friday, September 6th. The stock was sold at an average price of $165.52, for a total transaction of $286,846.16. Following the sale, the executive vice president now directly owns 13,471 shares in the company, valued at $2,229,719.92. The trade was a 0.00 % decrease in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available through the SEC website. Insiders own 0.51% of the company’s stock.

Clorox Company Profile

The Clorox Company manufactures and markets consumer and professional products worldwide. It operates through four segments: Health and Wellness, Household, Lifestyle, and International. The Health and Wellness segment offers cleaning products, such as laundry additives and home care products primarily under the Clorox, Clorox2, Scentiva, Pine-Sol, Liquid-Plumr, Tilex, and Formula 409 brands; professional cleaning and disinfecting products under the CloroxPro and Clorox Healthcare brands; professional food service products under the Hidden Valley brand; and vitamins, minerals and supplement products under the RenewLife, Natural Vitality, NeoCell, and Rainbow Light brands in the United States.